Back to browse

Sustained Dystrophin Expression Induced by Peptide-conjugated Morpholino Oligomers in the Muscles of mdx Mice

Paper ID

PAPER000205

Year

2008

DOI

10.1038/mt.2008.120

PMID

18545222

Journal

Molecular Therapy

Source URL

Experiments

• EXP001198 with CPP-A (PPMO-A) (PMO (morpholino antisense oligo))
• EXP001199 with CPP-B (PPMO-B) (PMO (morpholino antisense oligo))
• EXP001200 with CPP-C (PPMO-C) (PMO (morpholino antisense oligo))
• EXP001201 with CPP-D (PPMO-D) (PMO (morpholino antisense oligo))
• EXP001202 with CPP-E (PPMO-E) (PMO (morpholino antisense oligo))
• EXP001203 with CPP-F (PPMO-F) (PMO (morpholino antisense oligo))
• EXP001204 with CPP-G (PPMO-G) (PMO (morpholino antisense oligo))
• EXP001205 with CPP-H (PPMO-H) (PMO (morpholino antisense oligo))
• EXP001206 with CPP-I (PPMO-I) (PMO (morpholino antisense oligo))
• EXP001207 with CPP-J (PPMO-J) (PMO (morpholino antisense oligo))
• EXP001208 with CPP-K (PPMO-K) (PMO (morpholino antisense oligo))
• EXP001209 with CPP-L (PPMO-L) (PMO (morpholino antisense oligo))
• EXP001210 with CPP-M (PPMO-M) (PMO (morpholino antisense oligo))
• EXP001211 with CPP-N (PPMO-N) (PMO (morpholino antisense oligo))
• EXP001212 with CPP-B conjugate (M23D-B, dystrophin-targeting PPMO) (PMO (morpholino antisense oligo))
• EXP001213 with CPP-B conjugate (mis-23D-B, mismatched PMO control) (PMO (morpholino antisense oligo))